Abbott Laboratories
DUS:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
DUS:ABL
|
US |
|
S
|
Siam Wellness Group PCL
SET:SPA
|
TH |
|
B
|
Bed Bath & Beyond Inc
XMUN:OVER
|
US |
|
H
|
HB Fuller Co
F:HB1
|
US |
|
R
|
Ramada Investimentos e Industria SA
F:Y4E
|
PT |
|
N
|
Nomura Holdings Inc
XMUN:NSE
|
JP |
|
M
|
Moody's Corp
XMUN:DUT
|
US |
|
L
|
Lakeland Industries Inc
F:LLI
|
US |
|
A
|
Abb Ltd
XMUN:ABJA
|
CH |
|
D
|
Deutsche Bank AG
XMUN:DBK
|
DE |
|
C
|
Canadian Tire Corporation Ltd
F:YAAA
|
CA |
|
D
|
Duke Energy Corp
F:D2MN
|
US |
|
Rio Tinto Ltd
F:CRA1
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
105.41
EUR
According to Wall Street analysts, the average 1-year price target for 
ABL is 105.41 EUR with a low forecast of 89.59 EUR and a high forecast of 122.98 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
18%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 18%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.